| Removal of protein-bound uremic toxins during hemodialysis using a binding competitor M Madero, KB Cano, I Campos, X Tao, V Maheshwari, J Brown, ... Clinical Journal of the American Society of Nephrology 14 (3), 394-402, 2019 | 119 | 2019 |
| Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study X Tao, S Thijssen, P Kotanko, CH Ho, M Henrie, E Stroup, G Handelman Scientific reports 6 (1), 23389, 2016 | 82 | 2016 |
| In silico comparison of protein-bound uremic toxin removal by hemodialysis, hemodiafiltration, membrane adsorption, and binding competition V Maheshwari, S Thijssen, X Tao, DH Fuertinger, F Kappel, P Kotanko Scientific Reports 9 (1), 909, 2019 | 38 | 2019 |
| Enhanced indoxyl sulfate dialyzer clearance with the use of binding competitors X Tao, S Thijssen, N Levin, P Kotanko, G Handelman Blood purification 39 (4), 323-330, 2015 | 35 | 2015 |
| A novel mathematical model of protein-bound uremic toxin kinetics during hemodialysis V Maheshwari, S Thijssen, X Tao, D Fuertinger, F Kappel, P Kotanko Scientific Reports 7, 2017 | 31 | 2017 |
| Removal of protein-bound uremic toxins using binding competitors in hemodialysis: a narrative review V Maheshwari, X Tao, S Thijssen, P Kotanko Toxins 13 (9), 622, 2021 | 26 | 2021 |
| Tryptophan and kynurenine levels and its association with sleep, nonphysical fatigue, and depression in chronic hemodialysis patients R Malhotra, V Persic, W Zhang, J Brown, X Tao, L Rosales, S Thijssen, ... Journal of Renal Nutrition 27 (4), 260-266, 2017 | 26 | 2017 |
| Clearance of p-cresol sulfate and β-2-microglobulin from dialysate by commercially available sorbent technology A Kruse, X Tao, V Bhalani, G Handelman, NW Levin, P Kotanko, ... ASAIO journal 57 (3), 219-224, 2011 | 13 | 2011 |
| Performance of the surprise question compared to prediction models in hemodialysis patients: a prospective study R Malhotra, X Tao, Y Wang, Y Chen, RH Apruzzese, P Balter, Q Xiao, ... American Journal of Nephrology 46 (5), 390-396, 2017 | 12 | 2017 |
| The membrane perspective of uraemic toxins: which ones should, or can, be removed? SK Bowry, P Kotanko, R Himmele, X Tao, M Anger Clinical Kidney Journal 14 (Supplement_4), i17-i31, 2021 | 9 | 2021 |
| Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study. Sci Rep. 2016; 6: 23389 X Tao, S Thijssen, P Kotanko, CH Ho, M Henrie, E Stroup, G Handelman External Resources Crossref (DOI), 2016 | 7 | 2016 |
| SARS-CoV-2 in spent dialysate from chronic peritoneal dialysis patients with COVID-19 PKNG Xiaoling Wang, Amrish Patel, Lela Tisdale, Zahin Haq, Xiaoling Ye ... | 7* | |
| Estimation of fluid status using three multifrequency bioimpedance methods in hemodialysis patients LC Wang, JG Raimann, X Tao, P Preciado, O Thwin, L Rosales, ... Hemodialysis International 26 (4), 575-587, 2022 | 6 | 2022 |
| Effect of statewide lockdown in response to COVID-19 pandemic on physical activity levels of hemodialysis patients M Han, P Preciado, O Thwin, X Tao, LM Tapia-Silva, LR Fuentes, ... Blood Purification 50 (4-5), 602-609, 2021 | 6 | 2021 |
| A model-based analysis of phenytoin and carbamazepine toxicity treatment using binding-competition during hemodialysis V Maheshwari, RS Hoffman, S Thijssen, X Tao, DH Fuertinger, P Kotanko Scientific Reports 10 (1), 11294, 2020 | 5 | 2020 |
| Systems and methods for analyzing spent dialysate P Kotanko, X Tao, MG Garbaccio, S Thijssen, N Grobe, LMT Silva US Patent App. 16/739,366, 2021 | 4 | 2021 |
| Removal of Middle Molecules and Dialytic Albumin Loss: A Cross-over Study of Medium Cutoff and High-Flux Membranes with Hemodialysis and Hemodiafiltration A Armenta-Alvarez, S Lopez-Gil, I Osuna, N Grobe, X Tao, GF Dias, ... Kidney360 4 (8), 1095-1102, 2023 | 2 | 2023 |
| Transfer of low-molecular weight single-stranded DNA through the membrane of a high-flux dialyzer X Tao, N Hoenich, SK Handelman, NW Levin, P Kotanko, GJ Handelman The International Journal of Artificial Organs 37 (7), 529-538, 2014 | 2 | 2014 |
| Allo-Hemodialysis, a Novel Dialytic Treatment Option for Patients with Kidney Failure: Outcomes of Mathematical Modelling, Prototyping, and Ex Vivo Testing V Maheshwari, N Grobe, X Wang, A Patel, A Cherif, X Tao, J Chao, ... Toxins 16 (7), 292, 2024 | 1 | 2024 |
| Compounds, systems, and techniques for removal of peripheral amyloid beta peptide with albumin binding competitors X Tao, P Kotanko, S Thijssen, V Maheshwari US Patent App. 18/083,827, 2023 | 1 | 2023 |
Peter KotankoRenal Research Institute, New York, NY確認したメール アドレス: rriny.com